Growing community of inventors

Mannheim, Germany

Sylvia Luxen

Average Co-Inventor Count = 6.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 13

Sylvia Luxen ↔ Ugur Sahin (3 patents)Sylvia Luxen ↔ Ozlem Tureci (3 patents)Sylvia Luxen ↔ Michael Koslowski (3 patents)Sylvia Luxen ↔ Özlem Türeci (52 patents)Sylvia Luxen ↔ Korden Walter (3 patents)Sylvia Luxen ↔ Maria Kreuzberg (3 patents)Sylvia LuxenSylvia Luxen (3 patents)Ugur SahinUgur Sahin (182 patents)Ozlem TureciOzlem Tureci (53 patents)Michael KoslowskiMichael Koslowski (53 patents)Özlem TüreciÖzlem Türeci (52 patents)Korden WalterKorden Walter (18 patents)Maria KreuzbergMaria Kreuzberg (15 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Johannes Gutenberg-Universität Mainz (3 from 44 patents)

2. Ganymed Pharmaceuticals Ag (2 from 50 patents)

3. Ganymed Pharmaceuticals Gmbh (1 from 10 patents)

4. Astellas Pharma Gmbh (416 patents)

5. Tron—translationale Onkologie An Der Universitátsmedizin Der Johannes Gutenberg—universitÄt Mainz Gemeinnützige Gmbh (23 patents)


3 patents:

1. 10844133 - Cancer therapy using CLDN6 target-directed antibodies in vivo

2. 9902778 - Cancer therapy using CLDN6 target-directed antibodies in vivo

3. 9718886 - Cancer therapy using CLDN6 target-directed antibodies in vivo

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/9/2025
Loading…